{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:03:53Z","timestamp":1762506233109},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/coc.0000000000000020","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T09:12:37Z","timestamp":1388740357000},"page":"64-68","source":"Crossref","is-referenced-by-count":9,"title":["Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy"],"prefix":"10.1097","volume":"39","author":[{"given":"Drew","family":"Moghanaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo I.","family":"Urdaneta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D.","family":"Karlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bridget F.","family":"Koontz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell S.","family":"Anscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210128","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1001\/jama.299.23.2760","article-title":". Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy.","volume":"299","author":"Trock","year":"2008","journal-title":"JAMA"},{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1002\/cncr.25993","article-title":". Salvage radiation in men after prostate-specific antigen failure and the risk of death.","volume":"117","author":"Cotter","year":"2011","journal-title":"Cancer"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/COC.0b013e3182005319","article-title":". ACR appropriateness criteria postradical prostatectomy irradiation in prostate cancer.","volume":"34","author":"Rossi","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"R4-11-20210128","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1200\/JCO.1999.17.4.1155","article-title":". Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.","volume":"17","author":"Cox","year":"1999","journal-title":"J Clin Oncol"},{"key":"R5-11-20210128","first-page":"5436","article-title":"Practice patterns for post-prostatectomy hormonal therapy amongst Canadian radiation oncologists.","volume":"17","author":"Baxi","year":"2010","journal-title":"Can J Urol"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":". EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur Urol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1368-5031.2004.00184.x","article-title":". Management of prostate-specific antigen relapse in prostate cancer: a European Consensus.","volume":"58","author":"Boccon-Gibod","year":"2004","journal-title":"Int J Clin Pract"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ijrobp.2009.02.006","article-title":". Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer.","volume":"76","author":"Michalski","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2007.07.017","article-title":". Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group.","volume":"84","author":"Poortmans","year":"2007","journal-title":"Radiother Oncol"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.radonc.2008.05.006","article-title":". Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group.","volume":"88","author":"Sidhom","year":"2008","journal-title":"Radiother Oncol"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2007.04.068","article-title":". Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy.","volume":"69","author":"Wiltshire","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.juro.2008.11.032","article-title":". Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.","volume":"181","author":"Thompson","year":"2009","journal-title":"J Urol"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(05)67101-2","article-title":". Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).","volume":"366","author":"Bolla","year":"2005","journal-title":"Lancet"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":". Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02AUO AP 0995.","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1016\/j.ijrobp.2011.04.003","article-title":". Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy.","volume":"82","author":"Showalter","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.juro.2010.08.086","article-title":". Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials.","volume":"185","author":"Hoffman","year":"2011","journal-title":"J Urol"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2008.11.042","article-title":". Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.","volume":"75","author":"Fakiris","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-11-20210128","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2007.09.047","article-title":"Improved outcomes with higher doses for salvage radiotherapy after prostatectomy.","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R19-11-20210128","first-page":"S357","article-title":". Long-term outcomes of postprostatectomy salvage radiation therapy (PsRT) dose intensification (81Gy).","volume":"84","author":"Mourad","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-11-20210128","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ijrobp.2007.02.035","article-title":"Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients.","volume":"69","author":"Spiotto","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cncr.27712","article-title":". Elective irradiation of pelvic lymph nodes during postprostatectomy salvage radiotherapy.","volume":"119","author":"Moghanaki","year":"2013","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:57:54Z","timestamp":1620950274000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000421-201602000-00011"}},"subtitle":["Results of an International Survey"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000020","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}